BioSpace News Archive

Transparency Market Research, New York: The shifting trend of manufacturers from glass to plastic may serve as a prominent growth multiplying factor for the healthcare packaging market.

Relevant issues like sanitation, neatness, and cleanliness still stress a few pieces of the world even

MaaT Pharma announced the appointment of Claude Bertrand, PharmD, PhD, as an independent member to the company’s Board of Directors and welcomes John Weinberg, MD, as new Chief Medical Officer.

Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, announced that it has successfully completed a CHF 7.5 million Series B equity financing round.

4 evaluable GNAQ/11 mutation skin melanoma patients enrolled in Stage 1 cohort with a 100% Disease Control Rate (excluding 1 non-evaluable) and 1 confirmed partial response by RECIST 1.1 guidelines

Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation devices for the treatment of urinary and bowel dysfunction, will report financial results for the second quarter of 2020 after the market closes on Thursday, August 6, 2020.

Emergent BioSolutions Inc. will host a conference call on Thursday, July 30, 2020 at 5:00 pm to discuss the financial results for the second quarter of 2020, recent business developments, revenue guidance for the third quarter of 2020, and financial outlook for full year 2020.

BIOLASE, Inc., a global leader in dental lasers, announced the expiration of the Company’s rights offering, which was oversubscribed.

The Clorox Company and Cleveland Clinic announced that they are bringing together their expertise to support public health as society continues to face COVID-19, while helping to instill confidence in the safety of public spaces among caregivers, patients, businesses and communities.

First-of-its-kind preclinical study shows that Niagen® resolves social deficits and anxiety-like behaviors in male mice